Arcturus Therapeutics Holdings' (NASDAQ:ARCT) Investors Will Be Pleased With Their Impressive 284% Return Over the Last Five Years

Yahoo FinanceApr 29 22:11

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024

Arcturus Therapeutics Holdings Inc. ((the "Company", "Arcturus", NASDAQ:ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and

BusinesswireApr 26 04:01

We're Interested To See How Arcturus Therapeutics Holdings (NASDAQ:ARCT) Uses Its Cash Hoard To Grow

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring

Simply Wall StApr 17 18:25

As More Rare Disease Therapies Launch, Their Prices Are Rising

Seeking AlphaApr 17 00:22

Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares

Yahoo FinanceMar 28 13:34

Arcturus Therapeutics(ARCT.US) Officer Sells US$610.57K in Common Stock

$Arcturus Therapeutics(ARCT.US)$ Officer Chivukula Pad sold 17,435 shares of Common Stock on Mar 25, 2024 at an average price of $35.02 for a total value of $610.57K.Source: Announcement What is state

Futu NewsMar 28 04:58